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Abstract. Two isoforms of brain ankyrin, 440- and 220- 
kD ankyrinB, are generated from the same gene by al- 
ternative splicing of pre-mRNA. The larger isoform 
shares the same NH2-terminal and COOH-terminal do- 
mains to the smaller isoform and contains, in addition, 
a unique inserted domain of about 220-kD in size (Ku- 
nimoto, M., E. Otto, and V. Bennett. 1991. J. Cell Biol. 
115:1319-1331). Both Isoforms were expressed in pri- 
mary cerebellar cells in a manner similar to that in vivo; 
the larger isoform appeared first when axogenesis is ac- 
tively conducted and the smaller isoform came up later. 
440-kD ankyrin  B was localized in the axons of cerebel- 
lar neurons both in vivo and in vitro using an antibody 
raised against the insert region, while 220-kD isoform 
was rather localized in the cell bodies and dendrites of 
neurons by a specific antibody prepared using a syn- 
thetic peptide corresponding to the splice site as anti- 
gen. Astroglia cells also expressed 220-kD ankyrinB but 
not the 440-kD isoform. These results indicate that 440- 
kD ankyrina is a neuron-specific isoform targeted to 
the axons and its unique inserted domain is essential for 
the targeting. 
KYRINS  are  a  family  of  spectrin-binding  proteins 
that  link  the  spectrin/actin network  to  the  cyto- 
plasmic domain of integral proteins that include 
ion  channels  and  cell adhesion  molecules  (Bennett and 
Gilligan, 1993; Davis et al., 1993).  Ankyrins contain three 
domains;  an NH2-terminal 89-95-kD  membrane binding 
domain (Davis and Bennett, 1990), a 62-kD domain that 
binds spectrin (Bennett, 1978)  and a COOH-terminal do- 
main  that is the  target of alternative splicing and is  the 
most variable domain among different ankyrins. The mem- 
brane binding domain contains 24 tandem repeats of 33- 
amino acids which are necessary and sufficient for associa- 
tion  of  ankyrin  with  the  erythrocyte  anion  exchanger 
(Davis and Bennett, 1990; Davis et al., 1991), the voltage- 
dependent sodium channel  (Srinivasan  et al.,  1992)  and 
nervous system cell adhesion molecules related to L1 and 
neurofascin (Davis et al., 1993; Davis and Bennett, 1994). 
Three different ankyrins are currently known to be ex- 
pressed in brain tissue: ankyrinR, which is also expressed in 
erythrocytes; ankyrinB, which is the major ankyrin in the 
brain;  and  ankyrinc,  which  is  localized in  axonal  initial 
segments  and  nodes  of  Ranvier  of  myelinated  axons 
(Kordeli et  al.,  1990,  1995).  AnkyrinB includes  two iso- 
forms of 220-kD and 440-kD which are products of alter- 
natively spliced  pre-mRNAs  encoded  by  a  single  gene 
(Kunimoto et al., 1991; Otto et al., 1991). 220-kD ankyrinB 
is the major isoform in adult brain (Kordeli et al., 1990), 
while 440-kD ankyrin  s is maximally expressed in develop- 
ing neonatal rat brain, with a peak at postnatal day 10, and 
decreases to about 30% of the maximal level in adult brain 
(Kunimoto et al., 1991). 440-kD ankyrinB shares the same 
NHE-terminal  and  COOH-terminal  domains  as  220-kD 
ankyrinB and contains, in addition, an inserted domain of 
220-kD  located  between the  membrane/spectrin-binding 
domains and the COOH-terminal domain (Kunimoto et 
al., 1991; Otto et al.,  1991; Chan et al., 1993).  Immunocy- 
tochemical staining  of developing rat cerebellum (Kuni- 
moto et al., 1991) and optic nerve (Chan et al., 1993)  im- 
plies  that  440-kD  ankyrinB is  localized to unmyelinated 
axons and premyelinated axons. 
Localization of 220-kD ankyrina, however, has not been 
clearly demonstrated, because this isoform is totally sub- 
sumed within the 440-kD isoform, which prevents the pro- 
duction of specific antibodies by standard strategies using 
recombinant proteins as antigens. 
In this paper, a  synthetic peptide corresponding to the 
splice site was designed to prepare a polyclonal antibody 
which can recognize the 220-kD isoform specifically. Us- 
ing these antibodies the expression and localization of the 
two ankyrinB isoforms in cerebellar cells in vivo and in 
vitro was investigated, and the evidence showing that 440- 
kD ankyrina is a neuron-specific isoform and the inserted 
domain of 440-kD ankyrinB is essential for the targeting of 
this isoform to the axon is presented. 
Materials and Methods 
Materials 
125I-Protein A was from ICN Radiochemicals (Irvine, CA). All tissue cul- 
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Figure 1.  Schematic organization of ankyrinB isoforms. Recombi- 
nant proteins corresponding to regions 1 and 2 were used as anti- 
gens to prepare polyclonal antibodies  1  and 2,  respectively and 
synthetic peptide corresponding to the region 3 was used to pre- 
pare antibody 3. 
ture media, sera and supplements were from GIBCO BRL (Gaithersburg, 
MD). Mouse monoclonal antibodies against microtubule associated pro- 
tein 2 (MAP2),  1 glial fibrillary acidic protein (GFAP), growth-associated 
protein-43 (GAP-43), and tau were purchased from Boehringer Mann- 
heim Biochemicals (Indianapolis, IN). Rabbit anti-mouse IgG, goat anti- 
rabbit IgG (TRITC-labeled), goat anti-mouse lgG (FITC-labeled), nor- 
mal goat serum, Triton-X-100, pepstatin A, leupeptin, and diisopropyl flu- 
orophosphate (DFP)  were from Sigma Chemical Co.  (St.  Louis, MO). 
Peptides were synthesized with a peptide synthesizer (model 9050; Milli- 
Gen/Biosearch). 
Antibodies Preparation 
Antibodies 1 and 2, both rabbit polyclonal, were prepared using recombi- 
nant proteins as antigens as described before (Kunimoto et al., 1991). An- 
tibody 1 raised against the recombinant protein corresponding to region 1 
in Fig. 1 recognizes 440-kD isoform specifically. Antibody 2 raised against 
region 2 in Fig. I recognizes both 440- and 220-kD isoforms. 
Antibody 3, a  rabbit polyclonal antibody, was prepared using a  syn- 
thetic peptide (TSEKNPQDEQC) coupled to a carrier protein (inject ma- 
leimide activated bovine serum albumin; Pierce Chemical Co., Rockford, 
IL) through the cysteine residue at the carboxy terminus as antigen and 
affinity purified using a column of the recombinant protein corresponding 
to the region 2, which includes the ten amino acid sequence, coupled to 
Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ). 
Cell Culture 
Cerebellar cells were prepared from neonatal Wistar rats within 24 h after 
birth, plated onto poly-lysine-coated dishes or glass coverslips, and main- 
tained in serum-free medium as described previously (Kunimoto et al., 
1992). 
Gel Electrophoresis and Immunoblot Analysis 
Rat cerebella were dissected from Wistar rats of various ages and homog- 
enized in 9 vol of 0.32 M sucrose containing 1 mM EGTA, pH 7.4, 1 mM 
NaN  3,  10 I.~g/ml pepstatin A, leupeptin, and 0.01%  DFP. The homoge- 
hates were mixed with SDS-sample buffer and heated at 65°C for 20 min. 
Samples were electrophoresed on SDS-polyacrylamide gradient gels and 
were immunoblotted using 125I-protein  A  to  visualize antibodies as de- 
scribed by Davis and Bennett (1983)  after electrophoretic transfer to Im- 
mobilon P membrane (Millipore Corp., Bedford, MA). 
Cultured  cells on  plastic plates  were  washed  once with  Dulbecco's 
phosphate-buffered saline, mixed with SDS-sample buffer, scraped off 
from the plates, and heated at 65°C  for 20  min. Samples were electro- 
phoresed and immunoblotted in the same way. 
Immunocytochemical Procedures 
Cells grown on coverglasses coated with poly-L-lysine were fixed with 4 % 
1. Abbreviations  used  in this  paper:  DFP,  diisopropyl fluorophosphate; 
DIV  9,  9  days  in  vitro;  GAP, growth-associated protein;  GFAP,  glial 
fibriltary acidic protein; MAP2, microtubule-associated protein 2. 
formaldehyde for 15 min at room temperature and washed three times 
with PBS. Fixed cells were permeabilized with 0.5% Triton X-100 in PBS 
and blocked with 10% normal goat serum and 1% bovine serum albumin 
in PBS for 30 min at room temperature. The coverglass was then incu- 
bated with 4 ~g/ml rabbit polyclonal antibodies against brain ankyrin iso- 
forms and mouse monoclonal antibodies against MAP2, GFAP, or tau in 
the presence of 0.05%  Triton  X-100 overnight at 4°C and washed five 
times with PBS containing 0.1% Tween 20. Ig molecules were visualized 
with TRITC-conjugated goat anti-rabbit IgG and FITC-conjugated goat 
anti-mouse lgG. 
Cryosections (10  ~m in thickness) of cerebellum were prepared from 
adult rats as described before (Kunimoto et al., 1991) and immuno-stained 
in the same way. 
Results 
Preparation of an Antibody Specific 
to 220-kD AnkyrinB 
An antibody specific to 220-kD ankyrinB has not been suc- 
cessfully prepared  by standard strategies using recombi- 
nant proteins as antigens, because this isoform is totally 
subsumed within the 440-kD isoform (Fig. 1). Therefore, a 
synthetic  peptide  corresponding  to  the  splice  site  (10 
amino acids, TSEKNPQDEQ, corresponding to the splice 
site plus an artificial C  at the carboxy terminus for cou- 
pling to bovine serum albumin, Fig. 1, region 3) was de- 
signed to prepare polyclonal antibodies which can recog- 
nize  the  220-kD  isoform specifically. Such  an  antibody 
(antibody 3),  raised against the synthetic peptide specifi- 
cally recognized 220-kD ankyrina by Western blot analysis 
of rat cerebellum, while an antibody against region 1 in 
Fig.  1  (antibody 1)  recognized 440-kD  ankyrinB specifi- 
cally and an antibody against region 2 (antibody 2) recog- 
nized both 440- and 220-kD isoforms (Fig. 2). 
Differential Expression of Two Brain Ankyrin Isoforms 
in Developing CerebeUar Cells 
During the course of cerebellar development in rats, 440- 
kD ankyrin~ appeared first and reached maximal expres- 
sion 10-15  d after birth, while 220-kD ankyrina appeared 
10 d after birth and attained maximal expression only in 
adult rats (Fig. 3). In primary cerebellar cells, the expres- 
sion of the two ankyrinB isoforms was regulated in a man- 
ner similar to that in vivo; the larger isoform appeared first 
and reached maximal expression after 9-d culture in vitro, 
Figure  2.  Specificity of anti- 
bodies.  Western  blot  analy- 
ses  of  rat  cerebellum  (28-d 
old)  were  performed  using 
antibodies  1  (b),  2  (c),  or  3 
(d).  Coomassie  blue-stained 
gel run in parallel with those 
used for immunoblotting was 
also shown (a). 
The Journal of Cell Biology, Volume 131, 1995  1822 Figure 3.  Expression of brain ankyrin isoforms in developing rat 
cerebellum. Western blot analyses of cerebellum from 1-, 9-, 16-, 
28-d old  and adult  rats  were performed using antibody 2 (b). 
Coomassie blue stained gel run in parallel with those used for im- 
munoblotting was also shown (a). 
while  the  smaller  isoform  appeared  later  and  reached 
maximal expression only after 13-d culture in vitro or later 
(Fig. 4). At 18 d  in vitro (DIV 18), 440-kD ankyrinB de- 
creased  significantly,  but  MAP2  also  decreased  in  the 
same way, indicating that cerebellar neurons were dying 
Figure 4.  Expression of brain ankyrin isoforms in rat cerebellar 
cells in primary culture. Western blot analyses of cerebellar cells 
cultured for 1, 5, 9, 13, 18 d in vitro were performed using anti- 
body 2 (b) or monoclonal antibody against MAP2 (c). Coomassie 
blue-stained gel run in parallel with those used for immunoblot- 
ting was also shown (a). 
out after prolonged culture period. The expression of 440- 
kD isoform is most active during the period of axogenesis 
both in vivo and in vitro, suggesting that this ankyrin iso- 
form is closely related to the axogenesis. 
It  is  noteworthy  that  a  150-kD  protein  was  also  ex- 
pressed  after  prolonged  culture  period,  when  neuronal 
cells were  dying out  (Fig.  4).  Although  this  isoform of 
ankyrin has not yet been well characterized (Otto et al., 
1991;  Kunimoto et  al.,  1991)  and  was  not  expressed so 
much in normal cerebellum (Fig. 3), 150-kD ankyrin may 
be a nonneuronal isoform of brain ankyrin. 
Immunocytochemical Localization  of Brain Ankyrin 
Isoforms in Rat Cerebellum 
In cryosections of adult rat cerebellum stained with dou- 
ble-label immunofluorescence, 440-kD ankyrina was local- 
ized in the molecular layer which is comprised of mainly 
parallel  fibers  from  granular  neurons,  dendrites  from 
Purkinje cells, and Bergman glias (Paley and Chan-Paley, 
1974) (Fig. 5, A  and C). The staining of 440-kD ankyrinB 
did not overlap with that of MAP2 (the dendrites and cell 
bodies of Purkinje cells were stained, Fig. 5 B) (Bernhardt 
and Matus,  1984) or with that of GFAP (Bergman glias 
were stained, Fig. 5 D)  (Schachner et al.,  1977), showing 
that 440-kD ankyrinB is localized in the parallel fibers in 
the molecular layer. Furthermore, the staining of 440-kD 
ankyrinB overlapped quite well with that of tau in molecu- 
lar layer and in white matter at unmyelinated stage of 16- 
d-old rats (Fig. 5, E  and F). In contrast, stronger staining 
of 220-kD ankyrinB was observed in the dendrites and cell 
bodies of Purkinje cells (Fig. 5  G), which is overlapping 
with that of MAP2 (Fig. 5 H), in addition to general weak 
staining. 
Immunocytoehemical Localization of Brain Ankyrin 
Isoforms in Cerebellar Cells in Primary Culture 
In primary cerebellar cells at 9 d in vitro (DIV 9), 440-kD 
ankyrinB was colocalized with tau in the axons (Fig. 6, A 
and B) stained by double-label immunofluorescence. Con- 
versely, the staining of 440-kD ankyrinB was complemen- 
tary to that of MAP2 (Fig. 6, D  and E, typical site is indi- 
cated by arrows), which was localized to the dendrites and 
cell bodies of neurons (Fig. 6 E). Stronger staining of 440- 
kD ankyrinB was observed at the fasciculated axons (Fig. 6 
G).  It  is  noteworthy that  440-kD  ankyrinB was  concen- 
trated at the tip of growing neurites in primary cerebellar 
neurons at DIV 1 (Fig. 7, A, D, and G, indicated by ar- 
rows). At this stage, the staining of 440-kD ankyrin  B was 
also complementary to that of MAP2 (Fig. 7 B) and was 
overlapping with that of tau, except that tau was not neces- 
sarily concentrated at the tip of neurites (Fig. 7 E). How- 
ever, GAP-43,  a  well-established marker  for the  axonal 
growth cone (Goslin et al., 1988; Liu et al., 1991), was not 
expressed very much and was not necessarily concentrated 
at the tip of growing neurites in the present culture system 
(Fig. 7 H). 
In contrast to 440-kD ankyrinB, the staining of the 220- 
kD isoform was quite similar to that of MAP2 (Fig. 8, A 
and B). In addition, 220-kD ankyrinB was localized in as- 
troglial cells which were not stained with anti-MAP2 anti- 
Kunimoto  Axonal Targeting of  440-kD Ankyrine  1823 body (Fig. 8, A  and B, indicated by arrows), but stained 
with anti-GFAP antibody (Fig. 8, D and E). 
Discussion 
This report describes the differential expression and local- 
ization of two alternatively spliced isoforms of brain an- 
kyrin, 440- and 220-kD ankyrin  B, in rat neural cells. 440-kD 
ankyrinB has been suggested to localize in unmyelinated 
or premyelinated axons by using specific antibodies raised 
against its unique insert (Kunimoto et al.,  1991;  Chan et 
al.,  1993).  However, the localization of 220-kD ankyrinB 
has not been clearly demonstrated, because this isoform is 
totally  subsumed  within  the  440-kD  isoform  (Fig.  1), 
which prevents successful production of specific antibod- 
ies by standard  strategies  using recombinant proteins as 
antigens.  The only unique sequence for the 220-kD  iso- 
form is the stretch corresponding to the junction between 
the spectrin-binding domain and the COOH-terminal do- 
main. 
In this study, a peptide of ten amino acids including the 
junction (Fig. 1, region 3) was synthesized and used as an 
antigen  to  produce polyclonal antibodies.  Such  an  anti- 
body, antibody 3, recognized the 220-kD isoform specifi- 
cally on the immunoblot, while antibody 1 recognized the 
440-kD isoform specifically and antibody 2 did both iso- 
forms (Fig. 2). Although the peptide sequence of the anti- 
gen  is  based  on  human  brain  ankyrin cDNA  sequence, 
antibody 3  can  detect  the  220-kD  isoform of rat  brain 
ankyrin, suggesting  that  rat  brain  ankyrin has  the  same 
amino acid sequence corresponding to the junction. These 
antibodies revealed the differential expression and local- 
ization of the two brain ankyrin isoforms in rat cerebellar 
cells. 
Both  Isoforms  were  expressed  in  primary  cerebellar 
cells in a manner similar to that in vivo; the larger isoform 
expressed maximally when axogenesis is actively conducted, 
while the smaller isoform came up later (Figs. 3 and 4). It 
is noteworthy that the 220-kD isoform did not decrease in 
parallel with MAP2 (Fig. 4)  at DIV  18 and was also ex- 
pressed in astroglial cells (Fig. 8), suggesting that the in- 
crease  in  the  amount  of this  isoform is  contributed  not 
only by neurons but also by glial cells. 
440-kD ankyrinB was localized in the axons of cerebellar 
neurons both in vivo (Fig. 5) and in vitro (Fig. 6) using an- 
tibody 1, while the 220-kD isoform was rather localized in 
the cell bodies and dendrites of neurons using antibody 3 
(Figs. 5 and 8). 
The Journal of Cell Biology, Volume 131,  1995  1824 Figure 5.  Immunocytochemical localization  of 440- and 220-kD ankyrinB in cerebellum from adult  rats.  Cryosections  of cerebellum 
from adult rat (A-D, G, and/4) or 16-d-old rat (E and F) were stained with double-label immunofluorescence using antibody 1 (A, C, 
and E) or antibody 3 (G), and monoclonal antibodies against MAP2 (microtubule-associated  protein 2) (B and H), GFAP (glial fibril- 
lary acidic protein) (D) or tau (F). Micrographs  in E-H were taken under a confocal microscope (MRC-1024; BioRad). Bar, 20 ~m. 
Based  on  these  results,  it  is  concluded  that  440-kD 
ankyrinB is a neuron-specific isoform, while 220-kD ankyrinB 
is rather general in neural tissue and is expressed both in 
neurons and glial cells. In addition, in neuronal cells 440- 
kD ankyrinB is sorted to the axons, while the 220-kD iso- 
form is abundant in the dendrites and cell bodies. 
To date, only a few proteins, such as GAP-43 (Goslin et 
al.,  1988;  Liu  et  al.,  1991)  and  certain  isoforms  of  tau 
(Binder et al.,  1986),  have been shown to be targeted to 
axons, but the sorting mechanism has not been elucidated. 
Although tau is abundant in the axons and MAP2 is local- 
ized  in  the  dendrites/cell  bodies  (Bernhardt  and  Matus, 
1984),  they share  a  homologous microtubule binding do- 
main in their COOH-terminal halves (Aizawa et al., 1988; 
Lee et al., 1988; Lewis et al., 1988).  So far, several possible 
mechanisms  for  the  selective  localization  of  tau  in  the 
axon and MAP2 in the dendrites have been suggested; first 
is the locally differing microtubule-binding affinities of the 
two proteins  (Kanai and  Hirokawa,  1995),  second is  the 
decreased transit  of MAP2  in  the  axons (Kanai and  Hi- 
rokawa, 1995), third is the selective stabilization of MAP2 
in  the  dendrites  and  tau  in  the  axons  (Okabe  and  Hi- 
rokawa, 1989),  and fourth is the  extended localization of 
mRNA in the dendrites (Garner et al., 1988). 
Furthermore,  MAP2C,  embryonic  isoform  of  MAP2 
produced by alternative splicing, has been shown to lack 
the cross-linking sidearm sequences  and dendritic target- 
ing signal of MAP2, resulting in uniform localization in the 
axon,  cell  body  and  dendrite  (Papandrikopoulou  et  al., 
1989). 
Kunimoto Axonal Targeting of  440-kD Ankyrin8  1825 Figure 6.  Immunocytochemical localization of 440-kD ankyrinB in primary cerebellar cells of rats. Cerebellar cells cultured for 9 d were 
stained with double-label immunofluorescence using antibody 1 (A, D, and G) and monoclonal antibodies against tau (B) or MAP2 (E 
and H), simultaneously. Corresponding phase contrast micrographs (C, F, and/) are also shown. Bar, 20 Ixm. 
In case of the two brain ankyrin isoforms, the 220-kD 
isoform is  abundant in the  dendrites/cell  bodies and the 
440-kD isoform is  localized in  the  axons,  although they 
share  the  same membrane  binding  and  spectrin binding 
domains (Fig.  1).  220-kD ankyrinB can be regarded as a 
naturally occurring deletion  mutant  of 440-kD  ankyrinB 
lacking the 220-kD inserted domain and is not sorted to 
the axons. Furthermore, the 220-kD inserted domain con- 
tains  several  short  stretches  of sequence  similarity  with 
GAP-43, suggesting the presence of a common mechanism 
for the  targeting  of these  axonal  proteins  (Chan  et  al., 
1993).  Taken  together,  it  is  strongly suggested  that  the 
220-kD  inserted  domain  plays  an  essential  role  for  the 
sorting of 440-kD ankyrinB to the axons. 
The  membrane  binding  domain  of brain  ankyrin  can 
bind  to  the  cytoplasmic  domains  of neurofascin/L1/Nr- 
CAM family of nervous system cell  adhesion molecules 
(Davis  and  Bennett,  1994).  Among them  L1  has  been 
shown to be localized in the molecular layer of the cere- 
bellum (Linder et al.,  1983),  which is quite similar to the 
The Journal of Cell Biology,  Volume 131, 1995  1826 Figure 7.  Immunocytochemical  localization of 440-kD ankyrinB in primary cerebellar cells of rats. Cerebellar cells cultured for 1 d were 
stained with double-label immunofluorescence  using antibody 1 (A, D, and G) and monoclonal  antibodies  against MAP2 (B), tau (E), 
or GAP-43 (H), simultaneously.  Corresponding phase contrast micrographs (C, F, and/) are also shown. Bar, 20 ixm. 
localization  of 440-kD  ankyrinB (Fig.  5).  It is,  therefore, 
possible  that  the  cytoplasmic domains  of integral  mem- 
brane proteins like L1 are involved in the differential lo- 
calization of the two brain ankyrin isoforms. In that case, 
however, modifying role of the inserted domain must be 
essential for the differential sorting, because the two brain 
ankyrin isoforms share the same membrane binding domain. 
At the earlier stage of neurite extension from cerebellar 
neurons in primary culture like DIV 1, only a little amount 
of 440-kD ankyrinB was expressed but was highly concen- 
trated at the growing tip of the neurites (Fig. 7), which is 
consistent with a previous observation that the expression 
of 440-kD ankyrinB is upregulated by the induction of neu- 
rite  extension  and  this  isoform is highly concentrated  at 
the  tip of growing neurites together with GAP-43 in  hu- 
man  neuroblastoma  NB-1  cells  (Kunimoto,  1995).  Al- 
though  440-kD  ankyrinB  was  not  well  colocalized  with 
GAP-43 in the present culture system, these facts may in- 
dicate that 440-kD ankyrinB plays an important role at the 
growth cone. 
Thus ankyrinB provides an interesting example of alter- 
native splicing in neurons which produces protein isoforms 
Kunimoto Axonal Targeting of  440-kD Ankyrin  8  1827 Figure 8.  Immunocytochemical lo- 
calization  of  220-kD  ankyrin  B  in 
primary  cerebellar  cells  of  rats. 
Cerebellar  cells  cultured  for  9  d 
were  stained  with  double-label 
immunofluorescence  using  anti- 
body  3  (A  and  D),  and  mono- 
clonal  antibodies  against  MAP2 
(B) or GFAP  (E), simultaneously. 
Corresponding phase contrast mi- 
crographs  (C  and  F)  are  also 
shown. Bar, 20 p~m. 
differentially  targeted  to  axons  and  dendrites/cell  bodies. 
In  addition,  ankyrinG,  another  member  of ankyrin  family 
expressed  in neuronal  cells, is targeted  to nodes  of Ranvier 
and  the  initial  segments  of  axons  (Kordeli  et  al.,  1991, 
1995)  and  also have  a  unique  insert  similar  to  that  of 440- 
kD  ankyrinB,  which  may  be  responsible  for  the  targeting. 
Ankyrins  will  perhaps  be  a  useful  model  for investigating 
protein  sorting in neurons. 
The author thanks Dr. Vann Bennett for useful suggestions and Drs. Chi- 
haru Tohyama and Tsuguyoshi Suzuki for their encouragement. 
This work was supported in part by Grant-in-Aid for International Sci- 
entific Research Program: Joint Research from the Ministry of Education, 
Science and Culture of Japan. 
Received for publication 19 June 1995 and in revised form 21 September 
1995. 
References 
Aizawa, H., H. Kawasaki, H. Murofushi, S. Kotani, K. Suzuki,  and H. Sakai. 
1988. Microtubule-binding domain of tau proteins. J. Biol.  Chem. 263:7703- 
7707. 
Bennett, V., and D. M. Gilligan.  1993. The spectrin-based membrane skeleton 
and micro-scale organization of the plasma membrane. Ann.  Rev. Cell Biol. 
9:27-66. 
Binder, L. I., A. Frankfurter, and L  I. Rebhun. 1986. Differential localization 
of MAP-2 and tau in mammalian neurons in situ. Ann.  N.Y. Acad.  Sci.  446: 
145-166. 
Brion, J. P., J. Guilleminot, and J. Nunez. 1988. Dendritic and axonal distribu- 
tion of the microtubule-associated  proteins MAP2 and tau in the cerebellum 
of the nervous mutant mouse. Dev. Brain Res. 44:221-232. 
Chart, W., E. Kordeli, and V. Bennett. 1993. 440-kD ankyrinB: structure of the 
major developmentally regulated domain and selective localization  in unmy- 
elinated axons. J. Cell Biol. 123:1463-1473. 
Davis, J., and V. Bennett. 1983. Brain spectrin:  isolation of subunits and forma- 
tion of hybrids with erythrocyte spectrin subunits. J. Biol.  Chem. 258:7757- 
7766. 
Davis, J. Q., and V. Bennett. 1994. Ankyrin binding activity shared by the neu- 
rofascin/L1/NrCAM family of nervous system cell  adhesion molecules. Z 
Biol. Chem. 269:27163-27166. 
Davis, J., T. Maclaughlin, and V. Bennett. 1993. Ankyrin binding proteins re- 
lated to nervous system  cell adhesion molecules: candidates to provide trans- 
membrane and intracenular connections in adult brain. J. Cell Biol. 121:121- 
133. 
Garner, C. C., R. P. Tucker, and A. Matus. 1988. Selective  localization  of mes- 
senger RNA for cytoskeletal protein MAP2 in dendrites. Nature  (Lond.). 
336:674--677. 
Goslin, K., D. J. Schreyer, J. H. P. Skene, and G. Banker. 1988. Development of 
neural polarity:  GAP-43 distinguishes axonal from dendritic growth cones. 
Nature (Lond.). 336:672-674. 
Kanai, Y., and N. Hirokawa.  1995. Sorting mechanisms of tau and MAP2 in 
neurons: suppressed axonal transit of MAP2 and locally regulated microtu- 
bule binding. Neuron. 14:421~,32. 
Kordeli, E., J. Davis, B. Trapp, and V. Bennett. 1990. An isoform of ankyrin is 
localized  at nodes of Ranvier in myelinated axons of central and peripheral 
nerves. J. Cell Biol. 110:1341-1352. 
Kordeli, E., S. Lambert, and V. Bennett. 1995. AnkyrinG: a new ankyrin gene 
with neural-specific isoforms localized at the axonal initial segment and node 
of Ranvier. Z Biol. Chem. 270:2352-2359. 
Kosik, K. S., and E. A. Finch. 1987. MAP2 and tau segregate into dendritic and 
axonal domains after the elaboration of morphologically distinct neurites. J. 
Neurosci. 7:3142-3153. 
The Journal of Cell Biology, Volume 131, 1995  1828 Kunimoto, M.  1995.  Possible involvement of 440-kD isoform of ankyrinB in 
neuritogenesis in human neuroblastoma NB-1 cells. FEBS (Fed. Eur.  Bio- 
chem. Soc.) Letr 357:217-220. 
Kunimoto, M., E. Otto, and V. Bennett. 1991. A new 440-kD isoform is the ma- 
jor ankyrin in neonatal rat brain. J. Cell Biol. 115:1319-1331. 
Kunimoto, M., Y. Aoki, K. Shibata, and T. Miura. 1992. Differential cytotoxic 
effects of methylmercury and organotin compounds on mature and imma- 
ture neuronal cells and non-neuronal cells in vitro. Toxicol. In Vitro. 4:349- 
355. 
Lee, G., N. Cowan, and M. W. Kirschner. 1988. The primary structure and het- 
erogeneity of tau protein from mouse brain. Science (Wash. DC).  239:285- 
288. 
Lewis, S. A., D. Wang, and N. J. Cowan. 1988. Microtubule-associated protein 
MAP2 shares a microtubule binding motif with tau protein. Science (Wash. 
DC). 242:936-939. 
Liu, Y., E. R.  Chapman, and D. R.  Storm.  1991. Targeting of neuromodulin 
(GAP-43)  fusion proteins to growth cones in cultured rat embryonic neu- 
rons. Neuron. 6:411-420. 
Okabe, S., and N. Hirokawa. 1989. Rapid turnover of microtubule-associated 
protein MAP2 in the axon revealed by microinjection of biotinylated MAP2 
into cultured neurons. Proc. Natl. Acad.  Sci. USA. 86:4127-4131. 
Otto, E., M.  Kunimoto, T. McLaughlin, and V. Bennett.  1991.  Isolation and 
characterization of cDNAs encoding human brain ankyrins reveal a family 
of alternatively  spliced genes. ,L Cell Biol. 114:241-253. 
Paley, S. L., and V. Chan-Paley. 1974. Cerebellar Cortex, Cytology and Organi- 
zation. Springer-Verlag, New York. 
Papandrikopoulou, A., T.  Doll, R.  P.  Tucker,  C. G.  Garner,  and A. Matus. 
1989. Embryonic MAP2 lacks the crosslinking sidearm sequences and den- 
dritic targeting signal of adult MAP2. Nature (Lond.).  340:650~52. 
Schachner, M., E. T. Hedley-Whyte, D. W. Hsu, G. Schoonmaker, and A. Big- 
nami. 1977.  Ultrastructural 16calization of glial fibrillary acidic protein in 
mouse cerebellum by immunoperoxidase labeling. Z  Cell BioL 75:67-73. 
Kunimoto Axonal Targeting of  440-kD Ankyrin  B  1829 